MIP
ABBV icon

Mondrian Investment Partners’s AbbVie ABBV Stock Holding History

Mondrian Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,191
Closed -$922K – 99
2024
Q4 		$922K Sell
5,191
-639,094
-99% -$118M 0.02% 70
2024
Q3 		$127M Sell
644,285
-199,612
-24% -$37.3M 1.93% 22
2024
Q2 		$156M Sell
843,897
-72,006
-8% -$11.9M 2.41% 10
2024
Q1 		$167M Sell
915,903
-51,920
-5% -$8.95M 2.29% 15
2023
Q4 		$150M Buy
967,823
+12,287
+1% +$1.79M 2.37% 10
2023
Q3 		$142M Sell
955,536
-132,802
-12% -$19.5M 2.93% 5
2023
Q2 		$147M Buy
1,088,338
+157,027
+17% +$23M 2.93% 10
2023
Q1 		$148M Buy
931,311
+70,741
+8% +$10.8M 3.28% 7
2022
Q4 		$139M Sell
860,570
-190,962
-18% -$29.3M 3.08% 10
2022
Q3 		$141K Buy
1,051,532
+18,126
+2% +$2.6M 3.09% 10
2022
Q2 		$158M Buy
1,033,406
+102,154
+11% +$15.6M 3.31% 6
2022
Q1 		$151M Sell
931,252
-159,274
-15% -$23.1M 3.1% 11
2021
Q4 		$148M Buy
1,090,526
+560,488
+106% +$66.2M 2.92% 11
2021
Q3 		$57.2M Buy
530,038
+73,841
+16% +$8.44M 1.15% 33
2021
Q2 		$51.4M Buy
456,197
+80,593
+21% +$9.08M 0.98% 34
2021
Q1 		$41.9M Buy
375,604
+61,129
+19% +$6.54M 0.9% 41
2020
Q4 		$33.7M Buy
314,475
+104,023
+49% +$10M 0.83% 43
2020
Q3 		$17.9M Sell
210,452
-89,564
-30% -$8.43M 0.62% 43
2020
Q2 		$29.5M Buy
+300,016
New +$26.4M 1.06% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mondrian Investment Partners's ABBV Position: Q1 2025 in Review

Mondrian Investment Partners sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 5,191 shares — an estimated $922K sold.

Mondrian Investment Partners first reported a position in ABBV in Q2 2020 and held it in 19 quarters. The position peaked at $167M in Q1 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Mondrian Investment Partners reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Mondrian Investment Partners sold 5,191 AbbVie shares in Q1 2025, an estimated $922K.
  • Mondrian Investment Partners first reported a position in AbbVie in Q2 2020 and held it in 19 quarters.
  • Mondrian Investment Partners's AbbVie position peaked at $167M in Q1 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Mondrian Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.